RIVERBRIDGE PARTNERS LLC

13F Filings History

Latest 13F report
Q3 2024 - Oct 15, 2024
Value $
$7.49B
Signature - Title
Lois Beckmen - Compliance Associate
Location
Minneapolis, MN
Summary
This page shows a list of all the recent 13F filings made by RIVERBRIDGE PARTNERS LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. RIVERBRIDGE PARTNERS LLC reported 182 stock holdings with total value $7.49B as of Q3 2024. Top holdings included NVDA, MSFT, GLOB, HEI, and RBA.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 182 $7.49B +$214M -$536M -$322M NVDA, MSFT, GLOB, HEI, RBA 13F-HR 10/15/2024, 02:16 PM
Q2 2024 178 $7.36B +$424M -$545M -$121M MSFT, NVDA, GLOB, LOPE, HEI 13F-HR 7/17/2024, 02:14 PM
Q1 2024 174 $8.2B +$172M -$481M -$309M GLOB, MSFT, RBA, MEDP, NVDA 13F-HR 4/26/2024, 04:21 PM
Q4 2023 202 $8B +$201M -$326M -$125M GLOB, FIVE, LOPE, RBA, MSFT Restatement 2/15/2024, 02:47 PM
Q3 2023 192 $7.33B +$268M -$424M -$156M GLOB, RBA, FIVE, LOPE, WK Restatement 2/15/2024, 02:55 PM
Q2 2023 192 $7.93B +$779M -$501M +$277M FIVE, GLOB, RBA, CSGP, MSFT 13F-HR 7/25/2023, 01:18 PM
Q1 2023 189 $7.13B +$234M -$463M -$229M FIVE, RBA, GLOB, LOPE, WK 13F-HR 4/21/2023, 01:45 PM
Q4 2022 195 $6.66B +$190M -$316M -$126M FIVE, RBA, GLOB, LOPE, CSGP 13F-HR 1/11/2023, 01:04 PM
Q3 2022 194 $6.73B +$827M -$226M +$602M GLOB, RBA, FIVE, PCTY, CSGP 13F-HR 10/26/2022, 10:27 AM
Q2 2022 195 $6.25B $0 $0 RBA, GLOB, LOPE, MSFT, FIVE New Holdings 8/29/2022, 03:02 PM
Q2 2022 199 $6.25B +$271M -$989M -$718M RBA, GLOB, LOPE, MSFT, FIVE 13F-HR 7/11/2022, 03:47 PM
Q1 2022 161 $8.85B +$658M -$599M +$58.9M GLOB, AMED, LOPE, RBA, FIVE 13F-HR 4/20/2022, 01:55 PM
Q4 2021 168 $10.1B +$584M -$519M +$64.8M GLOB, FIVE, WST, RBA, MSFT 13F-HR 1/14/2022, 05:01 PM
Q3 2021 156 $9.97B +$419M -$356M +$62.1M GLOB, RBA, FIVE, WST, LOPE 13F-HR 10/26/2021, 11:22 AM
Q2 2021 157 $9.85B +$1.12B -$373M +$746M GLOB, FIVE, RBA, LOPE, AMED 13F-HR 7/26/2021, 01:43 PM
Q1 2021 153 $8.78B +$632M -$714M -$82M GLOB, LOPE, FIVE, RBA, AMED 13F-HR 4/21/2021, 04:38 PM
Q4 2020 152 $9.05B +$684M -$135M +$549M GLOB, BL, FIVE, RBA, CSGP 13F-HR 1/22/2021, 04:00 PM
Q3 2020 148 $7.17B +$568M -$312M +$257M GLOB, RBA, FIVE, PRLB, CSGP 13F-HR 10/8/2020, 01:15 PM
Q2 2020 148 $6.37B +$324M -$247M +$77.1M GLOB, PRLB, CSGP, LOPE, BL 13F-HR 7/8/2020, 11:53 AM
Q1 2020 137 $4.78B +$200M -$258M -$57.9M CHE, CSGP, TDOC, LOPE, GLOB 13F-HR 4/13/2020, 03:43 PM
Q4 2019 138 $5.57B +$183M -$269M -$86M LOPE, CHE, PRLB, CSGP, RBA 13F-HR 1/14/2020, 03:59 PM
Q3 2019 134 $5.28B +$181M -$98.9M +$82.2M PRLB, CHE, CSGP, RBA, FIVE 13F-HR 10/11/2019, 04:03 PM
Q2 2019 136 $5.29B +$420M -$564M -$144M PRLB, CSGP, GLOB, LOPE, RBA 13F-HR 7/10/2019, 03:58 PM
Q1 2019 132 $5.15B +$161M -$560M -$400M ULTI, PRLB, HEI, RBA, LOPE 13F-HR 4/4/2019, 02:56 PM
Q4 2018 131 $4.8B +$278M -$461M -$183M PRLB, RBA, NATI, HCSG, CHE 13F-HR 1/14/2019, 11:11 AM
Q3 2018 131 $5.98B +$223M -$421M -$197M PRLB, ULTI, RBA, HEI, CHE 13F-HR 10/3/2018, 12:17 PM
Q2 2018 128 $5.55B +$252M -$403M -$150M PRLB, FIVE, RBA, CHE, LOPE 13F-HR 7/3/2018, 10:22 AM
Q1 2018 133 $5.48B +$283M -$208M +$74.8M LOPE, PRLB, NATI, ULTI, HEI 13F-HR 4/3/2018, 11:29 AM
Q4 2017 138 $5.17B +$159M -$360M -$201M LOPE, PRLB, RBA, ULTI, HCSG 13F-HR 1/24/2018, 02:32 PM
Q3 2017 139 $5.08B +$214M -$437M -$223M LOPE, CSGP, HCSG, PRLB, NATI 13F-HR 11/1/2017, 12:23 PM
Q2 2017 139 $5.23B +$382M -$456M -$73.5M NATI, LOPE, CSGP, ULTI, ATHN 13F-HR 7/24/2017, 09:26 AM
Q1 2017 135 $4.98B +$128M -$315M -$187M LOPE, NATI, ULTI, CSGP, CHE 13F-HR 4/25/2017, 10:01 AM
Q4 2016 133 $4.76B +$385M -$633M -$248M NATI, LOPE, ULTI, GNTX, CSGP 13F-HR 1/20/2017, 12:47 PM
Q3 2016 131 $5B +$246M -$359M -$113M CPHD, ULTI, CSGP, NATI, RBA 13F-HR 10/24/2016, 12:33 PM
Q2 2016 133 $4.82B +$173M -$362M -$189M ULTI, CSGP, RBA, HCSG, ATHN 13F-HR 8/1/2016, 04:53 PM
Q1 2016 135 $4.8B +$247M -$237M +$10.8M ULTI, CSGP, PRLB, LOPE, ATHN 13F-HR 4/27/2016, 02:41 PM
Q4 2015 138 $4.87B +$318M -$476M -$158M ULTI, CSGP, ATHN, BECN, CHE 13F-HR 1/28/2016, 05:20 PM
Q3 2015 135 $4.85B +$337M -$424M -$86.8M ULTI, CPHD, ATHN, CSGP, MD 13F-HR 10/23/2015, 04:00 PM
Q2 2015 134 $5.3B +$228M -$531M -$304M CPHD, ULTI, TRAK, CSGP, ROL 13F-HR 7/20/2015, 12:06 PM
Q1 2015 131 $5.56B +$394M -$197M +$197M CPHD, ULTI, CSGP, NATI, GNTX 13F-HR 4/23/2015, 09:39 AM
Q4 2014 129 $5.38B +$235M -$472M -$237M CPHD, ULTI, RBA, CSGP, ATHN 13F-HR 1/20/2015, 12:43 PM
Q3 2014 128 $5.13B +$377M -$711M -$335M CPHD, ULTI, NATI, ATHN, RBA 13F-HR 11/5/2014, 12:31 PM
Q2 2014 130 $5.74B +$413M -$60.5M +$352M CPHD, ULTI, NATI, PRAA, RBA 13F-HR 7/31/2014, 11:47 AM
Q1 2014 128 $5.53B +$250M -$178M +$71.9M CPHD, ULTI, PRAA, RBA, MD 13F-HR 5/9/2014, 12:10 PM
Q4 2013 126 $5.52B $0 $0 CPHD, ULTI, NATI, CSGP, ATHN 13F-HR 2/10/2014, 10:41 AM